NCT01284309View on ClinicalTrials.gov

A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Intraocular Pressure
Interventions
DRUG

Mirabegron

oral

DRUG

Placebo

oral

Trial Locations (2)

68502

Celerion, Lincoln

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY